Home   Categories   Grid

Subscribe Now

AstraZeneca CEO Pascal Soriot says 2018 results herald a new era of sustained growth

AstraZeneca CEO Pascal Soriot says 2018 results herald a new era of sustained growth

AstraZeneca CEO Pascal Soriot says 2018 results herald a new era of sustained growth

18 February 2019

The biopharmaceutical company has reported strong results for its cancer drugs and in the Chinese market


CMR Surgical appoints Ingeborg Øie as chief financial officer

CMR Surgical appoints Ingeborg Øie as chief financial officer

CMR Surgical appoints Ingeborg Øie as chief financial officer

15 February 2019

Company developing Versius surgical robot is continuing its growth


MedImmune brand retired as its work is integrated into AstraZeneca

MedImmune brand retired as its work is integrated into AstraZeneca

MedImmune brand retired as its work is integrated into AstraZeneca

14 February 2019

MedImmune name and logo will no longer be used but "proud legacy of scientific innovation remains", says company


BioStrata recruits five as it continues growth

BioStrata recruits five as it continues growth

BioStrata recruits five as it continues growth

06 February 2019

Histon-based life science communications company is also continuing to recruit


Progress for AstraZeneca and MedImmune on drug for children infected with respiratory virus

Progress for AstraZeneca and MedImmune on drug for children infected with respiratory virus

Progress for AstraZeneca and MedImmune on drug for children infected with respiratory virus

05 February 2019

The antibody therapy has made progress with both the US Food and Drug Administration and European Medicines Agency


SBRI cultivates two medtech firms with respiratory products

SBRI cultivates two medtech firms with respiratory products

SBRI cultivates two medtech firms with respiratory products

03 February 2019

Asthma care boost from organisations nurtured by Milton-based healthcare organisation


Abcam acquires California-based Calico Biolabs

Abcam acquires California-based Calico Biolabs

Abcam acquires California-based Calico Biolabs

28 January 2019

Deal expands the Cambridge life science firm's custom capabilities


AstraZeneca's new Cambridge HQ will be a 'phenomenal' place to work says Dr Mene Pangalos

AstraZeneca's new Cambridge HQ will be a 'phenomenal' place to work says Dr Mene Pangalos

AstraZeneca's new Cambridge HQ will be a 'phenomenal' place to work says Dr Mene Pangalos

25 January 2019

'Open, porous, collaborative' place will help bolster UK life sciences, says senior executive


£1.1m funding helps CamBioScience turn e-learning into AI-learning

£1.1m funding helps CamBioScience turn e-learning into AI-learning

£1.1m funding helps CamBioScience turn e-learning into AI-learning

19 January 2019

An interview with CEO Dr Chibeza Agley as Cambridge company secures investment for its OBRIZUM platform


A first look inside AstraZeneca's new £500m-plus global HQ and R&D centre on Cambridge Biomedical Campus

A first look inside AstraZeneca's new £500m-plus global HQ and R&D centre on Cambridge Biomedical Campus

A first look inside AstraZeneca's new £500m-plus global HQ and R&D centre on Cambridge Biomedical Campus

14 January 2019

We tour the striking building that could redefine what a pharma business looks like


Expedeon becomes a preferred supplier for Babraham-based Cell Guidance Systems

Expedeon becomes a preferred supplier for Babraham-based Cell Guidance Systems

Expedeon becomes a preferred supplier for Babraham-based Cell Guidance Systems

10 January 2019

Companies sign agreement for Lightning-Link Rapid Biotin technology


Sosei Heptares receives $15m for cancer therapy milestone

Sosei Heptares receives $15m for cancer therapy milestone

Sosei Heptares receives $15m for cancer therapy milestone

10 January 2019

Next-generation immuno-oncology candidate triggers AstraZeneca payment


How AstraZeneca achieved a fivefold increase in its new medicines success rate

How AstraZeneca achieved a fivefold increase in its new medicines success rate

How AstraZeneca achieved a fivefold increase in its new medicines success rate

09 January 2019

Dr Mene Panaglos explains how a change in culture led to dramatic results for the pharmaceutical company


Abcam expects double digit revenue growth

Abcam expects double digit revenue growth

Abcam expects double digit revenue growth

08 January 2019

Company says it is preparing for no-deal Brexit


AstraZeneca announces changes as world-renowned cancer expert joins

AstraZeneca announces changes as world-renowned cancer expert joins

AstraZeneca announces changes as world-renowned cancer expert joins

07 January 2019

CEO Pascal Soriot says company expects 'sustained growth' period as new R&D units and commercial units created


PetaGene secures $2.1m after deal with big pharma

PetaGene secures $2.1m after deal with big pharma

PetaGene secures $2.1m after deal with big pharma

04 January 2019

Genomics data compression firm was spun out of university in 2016


Chief scientist at AstraZeneca tells of huge potential of partnership with Cancer Research UK

Chief scientist at AstraZeneca tells of huge potential of partnership with Cancer Research UK

Chief scientist at AstraZeneca tells of huge potential of partnership with Cancer Research UK

30 December 2018

The biopharmaceutical company is teaming up with CRUK on a Functional Genomics Centre in Cambridge


Morphogen-IX: £18.4m boost for PAH medicine

Morphogen-IX: £18.4m boost for PAH medicine

Morphogen-IX: £18.4m boost for PAH medicine

27 December 2018

Pulmonary arterial hypertension (PAH) investment for preclinical trials of disease-modifying MGX292 drug candidate


Success of Accelerate@Babraham bio-incubator programme is showcased

Success of Accelerate@Babraham bio-incubator programme is showcased

Success of Accelerate@Babraham bio-incubator programme is showcased

23 December 2018

The first bio-incubator programme at the campus has given some exciting companies a significant boost


NHS prepares for genetic services era

NHS prepares for genetic services era

NHS prepares for genetic services era

13 December 2018

Cambridge-based Congenica underpins genomic service


This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies - Learn More